I am a
Home I AM A Search Login

Papers of the Week


Papers: 24 Aug 2019 - 30 Aug 2019


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Itch


2020 Jan


J Allergy Clin Immunol


145


1

Phase 2b Randomized Study of Nemolizumab in Adults with Moderate-Severe Atopic Dermatitis and Severe Pruritus.

Authors

Silverberg JI, Pinter A, Pulka G, Poulin Y, Bouaziz J-D, Wollenberg A, Murrell Dédée F, Alexis A, Lindsey L, Ahmad F, Piketty C, Clucas A
J Allergy Clin Immunol. 2020 Jan; 145(1):173-182.
PMID: 31449914.

Abstract

Nemolizumab targets the interleukin 31 receptor alpha subunit (IL-31RA) involved in atopic dermatitis (AD) pathogenesis.